newsfilter
← Latest News
Business Wire·

Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Last participant completed final study visit in the 16-week double-blind period of the pivotal Phase 3 LUCIDITY trial of avexitide in post-bariatric hypoglycemia; topline data on track and anticipated in late August